Purpose To evaluate the long-term efficacy and safety of infliximab for the treatment of
uveitis in Behçet's disease (BD). Design Retrospective multicenter study using a …

Purpose: To assess long-term efficacy and safety of infliximab for refractory Behçet disease
(BD) uveitis and to evaluate the effect of withdrawal of infliximab after achieving long-term …

Purpose To evaluate the long-term safety and efficacy of infliximab therapy for refractory
uveitis associated with Behçet's disease (BD). Methods We prospectively enrolled six …

Purpose: To assess the long-term efficacy and safety of infliximab therapy for the treatment
of Behçet's disease patients with ocular involvement who failed to respond or did not tolerate …

Objective To compare the efficacy of infliximab (IFX) versus adalimumab (ADA) as a first‐line
biologic drug over 1 year of treatment in a large series of patients with refractory uveitis due …

Objective To describe the effects of infliximab on refractory uveoretinitis in patients with
Behçet disease during the first year of treatment. Methods Data were collected prospectively …

Objective In a large series of White patients with refractory uveitis due to Behçet disease
(BD) being treated with infliximab (IFX), we assessed (1) long-term efficacy and safety of IFX …

In this open-label trial, ten male patients with active Behcet's uveitis were enrolled. Initially,
two infliximab infusions (5 mg/kg) were given at weeks 0 and 2. The patients continued to …

Aim To investigate the relationship between recurrence of uveitis and timing of infliximab in
patients with Behçet's disease. Methods Charts were retrospectively reviewed for 23 patients …

Purpose: To evaluate the 10-year drug retention rate of infliximab (IFX) in Behçet's disease
(BD)-related uveitis, the effect of a concomitant use of disease modifying anti-rheumatic …